Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Veeva Systems (VEEV) , which belongs to the Zacks Internet - Software industry.When looking at the last two reports, this provider of cloud-based software services for the life sciences industry has recorded a strong streak of surpassing earnings estimates. The company has topped estimates by 6.36%, on average, in the last two quarters.For the last reported q ...

Veeva Systems (VEEV) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, VEEV crossed above the 20-day moving average, suggesting a short-term bullish trend.The 20-day simple moving average is a well-liked trading tool because it provides a look back at a stock's price over a 20-day period. Additionally, short-term traders find this SMA very beneficial, as it smooths out short-term price trends and shows more trend reversal signals than ...

Complete suite of modern patient, prescriber, and national data products for today's complex therapies Compass Prescriber includes HCP-level projections for more than 4,000 brands and their prescriptions and procedures PLEASANTON, Calif., Jan. 30, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced the availability of the full Veeva Compass Suite of commercial data products for a more complete view into patient populations and HCP-level insight. Veeva Compass Prescriber and Veeva Compass Nationa ...

SOPA Images/LightRocket via Getty Images Investment Thesis Veeva Systems Inc. (NYSE:VEEV) has been a very volatile stock in the past 12 months. The stock is far from blemish-free. For one, there are significant questions over its sustainable go-forward revenue growth rates. On top of that, the previous 3 quarters have seen Veeva's non-GAAP operating margins compress. Despite these considerations, I declare that investors will in the next 12 months look back to $175 per share as an attractive entry point ...

Hiraman Summary I am recommending a buy rating for Veeva Systems (NYSE:VEEV). I think the business is well positioned to consolidate market share in an industry that is ripe for technology upgrades. The nature of VEEV solutions also means that they are very sticky and this enables VEEV to easily cross-sell other products to further anchor itself into the customer's workflow processes. As growth and margin recover, I expect the market to re-rate VEEV back to its normalized multiple of 37x forward EBITDA. ...

Veeva Systems (VEEV) closed at $209.38 in the latest trading session, marking a +1.08% move from the prior day. The stock exceeded the S&P 500, which registered a gain of 0.22% for the day. Elsewhere, the Dow gained 0.36%, while the tech-heavy Nasdaq added 0.32%.The provider of cloud-based software services for the life sciences industry's shares have seen an increase of 8.54% over the last month, surpassing the Computer and Technology sector's gain of 3.64% and the S&P 500's gain of 1.61%.Market participan ...

Complete life sciences GxP training solution delivers audit readiness PLEASANTON, Calif., Jan. 18, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that more than 350 companies are using Veeva training solutions to modernize employee qualification processes. A growing number of biopharmas are adopting end-to-end learning management for advanced employee education and compliance. "Veeva is helping us streamline GxP training to speed employee qualification and onboarding as we grow," said Debra ...

Veeva Systems宣布迁移临床研究 - 一家前20的生物制药公司和Veeva Services将25项正在进行的临床研究从传统的电子数据捕获（EDC）应用程序迁移到Veeva Vault EDC，这是行业首次[2] - 传统系统的锁定和风险问题一直是迁移研究的障碍，但Veeva Vault EDC的迁移能力使得生物制药公司可以可靠地将正在进行的研究从传统应用程序迁移到Veeva Vault EDC，从而降低费用、推动标准化并提供更好的研究站点体验[3] Veeva的全球领导地位 - Veeva是生命科学行业云软件的全球领导者，致力于创新、产品卓越和客户成功，为1000多家客户提供服务，包括全球最大的生物制药公司和新兴生物技术公司[5]

公司介绍 - Veeva Systems是全球生命科学行业的云软件领导者[1] 投资者关系 - Veeva Systems宣布参加虚拟投资者会议[1] - Veeva Systems的投资者关系网站用于披露重要非公开信息[2]

Veeva Systems Inc. (VEEV) recently announced that SK Life Science, Inc., a subsidiary of SK Biopharmaceuticals Co. Ltd., is using Veeva Vault Validation Management to streamline and accelerate its validation process. By adopting a validation solution with built-in best practices, SK Life Science is expected to execute digital validation while centralizing data and improving visibility.It is worth mentioning that SK Life Science is a renowned pharmaceutical company focused on accelerating the development of ...